C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 5/10 (2006.01) C12N 5/078 (2010.01) A61K 35/14 (2006.01) A61P 35/00 (2006.01) C12N 15/861 (2006.01)
Patent
CA 2571426
The invention refers to tumor-homing cells expressing the tumor necrosis factor-related apoptosis inducing ligand (TRIAL), particularly to CD34+ and NK cells transduced with adenoviral vectors coding for TRIAL. The cells of the invention are useful for the intravenous treatment of tumors, particularly of lymphoma.
La présente invention a trait à des cellules de localisation tumorale d'expression du ligand inducteur d'apoptose relié au facteur de nécrose tumorale (TRAIL), notamment aux cellules CD34+ et NK transduites avec des vecteurs adénoviraux codant pour le ligand TRAIL. Les cellules de l'invention sont utiles pour le traitement par voie intraveineuse de tumeurs, en particulier de lymphome.
Carlo-Stella Carmelo
Colotta Francesco
Gianni Alessandro M.
Dompe Pha.r.ma S.p.a.
Kirby Eades Gale Baker
LandOfFree
Tumor-homing cells engineered to produce tumor necrosis... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tumor-homing cells engineered to produce tumor necrosis..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tumor-homing cells engineered to produce tumor necrosis... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1443682